Rosanna Santos serves as a Principal at RCS Biotech Consulting, where she leverages her extensive expertise in market access and commercial strategy to drive impactful solutions for biotech clients of all sizes. With a robust background in market research and payer coverage trends, Rosanna excels...
Rosanna Santos serves as a Principal at RCS Biotech Consulting, where she leverages her extensive expertise in market access and commercial strategy to drive impactful solutions for biotech clients of all sizes. With a robust background in market research and payer coverage trends, Rosanna excels in developing tailored strategies that enhance product positioning and facilitate successful market entry. Her role involves not only the creation of comprehensive marketing materials but also the meticulous planning and execution of trade shows, ensuring that her clients effectively engage with key stakeholders in the industry.
A seasoned professional in interview and advisory board moderation, Rosanna skillfully navigates complex discussions, drawing out valuable insights that inform strategic decisions. Her project management capabilities allow her to oversee multiple initiatives simultaneously, ensuring that all aspects of a project align with client objectives and industry standards. Additionally, her experience as a conference representative enables her to stay abreast of the latest trends and innovations in biotech, further enriching her consulting practice.
Rosanna's commitment to mentoring emerging professionals in the field reflects her dedication to fostering growth and knowledge-sharing within the biotech community. By combining her skills in international sales, strategic planning, and tactical execution, she consistently delivers high-quality results that empower her clients to thrive in a competitive landscape. Whether guiding a startup through its first product launch or advising established firms on market access strategies, Rosanna Santos is a trusted partner in navigating the complexities of the biotech sector.